Mary Fenton
Director of Finance/CFO at CULLINAN THERAPEUTICS, INC.
Net worth: 108 880 $ as of 29/04/2024
Network origin in Mary Fenton first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY.
720
| Subsidiary | Miscellaneous Commercial Services | 720 |
| Subsidiary | Pharmaceuticals: Major | 38 | |
Connecticut Business & Industry Association
 Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988.
33
| Private Company | Miscellaneous Commercial Services | 33 |
| Public Company | Biotechnology | 17 | |
| Public Company | Pharmaceuticals: Major | 14 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.
1
| Subsidiary | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mary Fenton via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor Private Equity Investor Consultant / Advisor Private Equity Investor Consultant / Advisor | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Chief Executive Officer General Counsel Chief Operating Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| The Pennsylvania State University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | President Corporate Officer/Principal | |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Biotechnology | General Counsel Director of Finance/CFO | |
| University of Massachusetts | College/University | Undergraduate Degree Masters Business Admin | |
| University of South Florida | College/University | Graduate Degree Doctorate Degree | |
| CELGENE | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| Wayne State University (Michigan) | College/University | Undergraduate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Graduate Degree | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| New York University | College/University | Masters Business Admin Graduate Degree | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
IEcure, Inc.
 IEcure, Inc. BiotechnologyHealth Technology iECURE, Inc. is a gene editing company that focuses on developing therapies for liver disorders with significant unmet need. The company is based in Plymouth Meeting, PA, and the CEO of the company is Joseph Truitt. The company's approach involves mutation-agnostic in vivo gene insertion or knock-in editing, which has the potential to replace and restore the function of a dysfunctional gene, regardless of mutation. iECURE collaborates with the University of Pennsylvania's Gene Therapy Program to utilize their translational expertise and infrastructure. The company's management team has extensive experience in executing orphan drug and gene therapy clinical trials and successfully commercializing multiple products. iECURE's programs are currently focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases. | Biotechnology | Chief Executive Officer Director/Board Member | |
America's Health Insurance Plans, Inc.
 America's Health Insurance Plans, Inc. Life/Health InsuranceFinance America's Health Insurance Plans, Inc. is the national trade association representing the health insurance industry. AHIP's members provide health and supplemental benefits to more than 200 million Americans through employer-sponsored coverage, the individual insurance market, and public programs such as Medicare and Medicaid. AHIP advocates for public policies that expand access to affordable health care coverage to all Americans through a competitive marketplace that fosters choice, quality and innovation. The company is headquartered in Washington, DC. | Life/Health Insurance | Director/Board Member Director/Board Member | |
CIGNA HealthCare, Inc.
 CIGNA HealthCare, Inc. Managed Health CareHealth Services CIGNA HealthCare, Inc. provides medical benefit plans, dental coverage, behavioral health coverage, pharmacy benefits, and products and services. the company is headquartered in Bloomfield, CT. | Managed Health Care | President Corporate Officer/Principal | |
| LaSalle University | College/University | Undergraduate Degree Graduate Degree | |
| NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Photys Therapeutics, Inc.
 Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Comptroller/Controller/Auditor | |
| GRITSTONE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Chairman | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Doctorate Degree | |
| TESARO INC | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
LikeMinds, Inc. (Massachusetts)
 LikeMinds, Inc. (Massachusetts) Personnel ServicesCommercial Services LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA. | Personnel Services | Director/Board Member Director/Board Member | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
| University of Connecticut | College/University | Masters Business Admin Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| STANLEY BLACK & DECKER, INC. | Tools & Hardware | Human Resources Officer Corporate Officer/Principal | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman General Counsel | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Founder | |
| Babson College | College/University | Undergraduate Degree Masters Business Admin | |
| Purdue University | College/University | Undergraduate Degree Undergraduate Degree | |
| Indiana University | College/University | Masters Business Admin Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal |
Statistics
International
| United States | 50 |
| Switzerland | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 14 |
| Finance | 8 |
| Commercial Services | 4 |
| Health Services | 2 |
Operational
| Director/Board Member | 483 |
| Corporate Officer/Principal | 197 |
| Independent Dir/Board Member | 112 |
| President | 110 |
| Chief Executive Officer | 99 |
Most connected contacts
| Insiders | |
|---|---|
| Luke Evnin | 42 |
| Nicholas Simon | 33 |
| Thomas Ebeling | 33 |
| Alireza Etemad | 32 |
| William Young | 32 |
| Nicole Vitullo | 28 |
| Briggs Morrison | 26 |
| Mark Bertolini | 26 |
| Gary E. Frashier | 26 |
| Charles Shivery | 25 |
| Stephen Webster | 23 |
| Anthony Adam Rosenberg | 23 |
| Robert van Nostrand | 22 |
| Diana McKenzie | 21 |
| James M. Garvey | 20 |
- Stock Market
- Insiders
- Mary Fenton
- Company connections
